Streetbeat News

Analyst Ratings

MRVL

Cantor Fitzgerald analyst C J Muse has maintained an Overweight rating on Marvell Tech (NASDAQ:MRVL) and increased the price target from $80 to $85.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 5:23 pm

MDB

B of A Securities analyst Bradley Sills maintains a Buy rating on MongoDB (NASDAQ:MDB) but lowers the price target from $555 to $500.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 5:23 pm

BURL

B of A Securities analyst Lorraine Hutchinson maintains a Buy rating on Burlington Stores (NYSE:BURL) and raises the price target from $245 to $250.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 5:22 pm

BBAI

Cantor Fitzgerald analyst Yi Fu Lee has maintained an Overweight rating on BigBear.ai Holdings (BBAI) and increased the price target from $3 to $3.5.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 5:22 pm

BBAI

TD Cowen analyst Shaul Eyal maintains a Market Perform rating on BigBear.ai Holdings (BBAI) and raises the price target from $2 to $3.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 5:20 pm

MORF

Canaccord Genuity analyst Edward Nash maintains a Buy rating on Morphic Holding (NASDAQ:MORF) but lowers the price target from $68 to $66.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 5:16 pm

COST

DA Davidson analyst Michael Baker maintains a Neutral rating on Costco Wholesale (NASDAQ:COST) and raises the price target from $600 to $680.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 5:15 pm

L

Loews Corporation (NYSE:L) has seen a 27.45% decrease in short interest, now at 1.16 million shares or 0.74% of float, indicating a bullish sentiment. The short interest is below the peer group average of 1.85%, suggesting Loews is performing well compared to its peers. Short interest is a key indicator of market sentiment, with decreases often signaling bullish outlooks.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 5:15 pm

MDGL

Canaccord Genuity analyst Edward Nash maintains a Buy rating on Madrigal Pharmaceuticals (MDGL) and raises the price target from $336 to $338.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 5:15 pm

MDB

Canaccord Genuity analyst David Hynes maintains a Buy rating on MongoDB (NASDAQ:MDB) but lowers the price target from $450 to $435.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 5:14 pm